Physician profile
Dmitriy Kuznetsov
NPI 1477950467
$1,087.43
in general payments reported to CMS, 2019-2025
9 companies · $366 in 2025
The $366 reported for 2025 was more than what 87% of General Practice (Dentist) providers received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14.86 · 2020: $19.17 · 2021: $98.00 · 2022: $141 · 2023: $211 · 2024: $238 · 2025: $366.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $566 · Education: $150 · Entertainment: $98.86.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $565.56 |
| Education | $150.00 |
| Entertainment | $98.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimvie INC. | $341.99 | 2022-2024 | |
| Align Technology, INC. | $305.53 | 2021-2025 | Invisalign |
| Dentsply Sirona INC | $102.46 | 2020-2025 | Copal Cavity Varnish, Mis, Nupro |
| Orapharma, A Division of Bausch Health US, LLC | $99.97 | 2025 | Arestin |
| Keystone Dental INC. | $98.86 | 2025 | |
| Centrix INC | $83.00 | 2025 | |
| Solventum Corporation | $22.74 | 2025 | Clarity Aligners, 3m Clinpro |
| Biohorizons Implant Systems INC. | $18.02 | 2025 | Biohorizons Dental Implants |
| Philips North America LLC | $14.86 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dmitriy Kuznetsov listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.